Geoffrey Beran Rose - 01 Sep 2022 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
Chief Commercial Officer
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Geoffrey Beran Rose
Issuer symbol
LUNG
Transactions as of
01 Sep 2022
Net transactions value
-$18,372
Form type
4
Filing time
06 Sep 2022, 16:52:54 UTC
Previous filing
03 Jun 2022
Next filing
05 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale $6,648 -372 -0.2% $17.87 182,747 01 Sep 2022 Direct F1, F2
transaction LUNG Common Stock Sale $11,724 -655 -0.36% $17.90 182,092 01 Sep 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.
F2 Includes 1 share acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on August 15, 2022.
F3 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 1, 2022.